September 11, 2012 in Health
News Summary: Alzheimer drug may slow brain plaque
MORE DISAPPOINTMENT: Two major studies of an experimental Alzheimer’s drug show it doesn’t stop mental decline, the latest setback in finding a treatment for the mind-robbing disease.
HOPEFUL SIGN: There was a hint that the drug bapineuzumab, made by Pfizer Inc. and Johnson & Johnson, might help if given sooner, before the disease has caused too much damage and memory loss.
WHAT’S NEXT: Tests in patients with mild mental impairment or those with brain plaque who haven’t yet developed disease symptoms. More results on this drug and a similar one by Eli Lilly & Co. are expected next …
You have viewed 20 free articles or blogs allowed within a 30-day period. FREE registration is now required for uninterrupted access.
Registration Required
- log in to your Spokesman.com account for unlimited viewing and commenting access.
- Don't have a Spokesman.com account? Create a Spokesman.com profile and register for FREE access.
-
S-R Media, The Spokesman-Review and Spokesman.com are happy to assist you. Contact Customer Service by email or call 800-338-8801
MORE DISAPPOINTMENT: Two major studies of an experimental Alzheimer’s drug show it doesn’t stop mental decline, the latest setback in finding a treatment for the mind-robbing disease.
HOPEFUL SIGN: There was a hint that the drug bapineuzumab, made by Pfizer Inc. and Johnson & Johnson, might help if given sooner, before the disease has caused too much damage and memory loss.
WHAT’S NEXT: Tests in patients with mild mental impairment or those with brain plaque who haven’t yet developed disease symptoms. More results on this drug and a similar one by Eli Lilly & Co. are expected next month.
© Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Spokane7
Celtic Woman is coming to Spokane
Win tickets to Fleetwood Mac!
Please keep it civil. Don't post comments that are obscene, defamatory, threatening, off-topic, an infringement of copyright or an invasion of privacy. Read our forum standards and community guidelines.
You must be logged in to post comments. Please log in here or click the comment box below for options.
comments powered by Disqus